Actor Danny Glover reveals Alzheimer's diagnosis
Actor Danny Glover spoke about his Alzheimer's diagnosis in an interview with NBC's "Today" show, revealing that he has been living with the disease for several years.
Watch CBS News
Actor Danny Glover spoke about his Alzheimer's diagnosis in an interview with NBC's "Today" show, revealing that he has been living with the disease for several years.
A Parisian art enthusiast has won a Pablo Picasso painting with a $117 raffle ticket.
As more than 7 million Americans live with Alzheimer's, a North Texas family is urging caregivers to seek help early after struggling to navigate their mother's diagnosis.
Dr. Gladys Maestre found that close to 20% of people over 65 in the Rio Grande Valley have memory loss, versus around 12% on a national level.
The official clinic opening is scheduled for next week.
Cissy Houston performed alongside superstar musicians like Elvis Presley and Aretha Franklin.
American neurosurgeon Ali Rezai is pioneering ways to try to help people with drug addiction and with Alzheimer's disease. One experiment focuses beams of ultrasound on the brain.
FDA approval of the new Alzheimer's treatment, which will be branded as Kisunla, follows years of setbacks.
The NFL icon announced that his wife of over 30 years is in the early stages of Alzheimer's disease.
"I was so sad. I couldn't sleep. I felt dead," she said. "And then I spent a lot of time with Tony. He wanted nothing but my friendship and my voice."
Gail Youngdale of McKinney says the risks are worth the results she's already seeing. The now 80-year-old said she prayed and prayed until she found Kerwin Medical Center in Dallas, who had her try a Leqembi clinical trial.
Unlike previous drugs, this one seems to work, at least modestly, to slow the progression of the disease in patients with early Alzheimer's.
In the last year, we've heard a lot about artificial intelligence, or AI. Advancements in this field are progressing at a rapid pace, and this is especially true for the medical industry.
The National Institutes of Health just awarded $150 million to the UNT Health Science Center to continue its groundbreaking research on how the disease affects different racial and ethnic groups.
